Predictors of Transmural Non-Occlusive Mesenteric Ischemia in ICU Patients With Suspected Acute Mesenteric Ischemia
Recruiting
Observational Study
Non-Occlusive Mesenteric Ischaemia (NOMI)
Acute Mesenteric Ischemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- University of Tartu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute mesenteric ischemia (AMI) is a rare but life-threatening condition associated with high mortality and major diagnostic challenges due to nonspecific clinical presentation and limited reliable biomarkers. Critically ill patients in the intensive care unit (ICU) are at particularly high risk of non-occlusive mesenteric ischemia (NOMI), a subtype of AMI characterized by impaired mesenteric perf…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
\- Adult ICU patients in whom clinical suspicion of acute mesenteric ischemia is raised during their ICU stay.
Exclusion criteria
* Patients who develop acute mesenteric ischemia outside of the intensive care unit,
* Confirmed strangulating bowel obstruction,
* Individuals youn…
Contacts
No contact information available.